» Articles » PMID: 12044812

Sigma(2) Receptors Regulate Changes in Sphingolipid Levels in Breast Tumor Cells

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2002 Jun 5
PMID 12044812
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

sigma(2) Receptors induce apoptosis in various cell types. The sphingolipid, ceramide as well as the sphingoid bases are involved in cell proliferation. Sphingolipids of MCF-7/Adr- and T47D breast tumor cells were metabolically radiolabeled. The sigma(2) receptor agonists (+)-1R,5R-E-8-(3,4-dichlorobenzylidene)-5-(3-hydroxyphenyl)-2-methylmorphan-7-one (CB-184) and 1S,2R-(--)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)-cyclohexylamine (BD737) caused dose-dependent increases in [(3)H]ceramide, with concomitant decreases in [(3)H]sphingomyelin. Both effects were attenuated by the novel sigma(2) receptor antagonist, N-phenethylpiperidine oxalate (AC927). sigma(2) Receptors may produce effects on cell growth and apoptosis by regulating the sphingolipid pathway.

Citing Articles

HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic.

Leotta C, Barbaraci C, Fiorito J, Coco A, di Giacomo V, Amata E Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005993 PMC: 11859726. DOI: 10.3390/ph18020179.


Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.

Liu C, Mottinelli M, Nicholson H, McVeigh B, Wong N, McCurdy C Eur J Pharmacol. 2021; 906:174263.

PMID: 34144027 PMC: 8736263. DOI: 10.1016/j.ejphar.2021.174263.


Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis.

Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T Molecules. 2020; 25(22).

PMID: 33233619 PMC: 7699687. DOI: 10.3390/molecules25225439.


PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.

Motawe Z, Abdelmaboud S, Cuevas J, Breslin J Int J Biochem Cell Biol. 2020; 126:105803.

PMID: 32668330 PMC: 7484451. DOI: 10.1016/j.biocel.2020.105803.


Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.

Oyer H, Sanders C, Kim F Front Pharmacol. 2019; 10:1141.

PMID: 31695608 PMC: 6816035. DOI: 10.3389/fphar.2019.01141.